Try our Advanced Search for more refined results
In re Arrowhead Research Corp., Securities Litigation
Case Number:
2:14-cv-07890
Court:
Nature of Suit:
Multi Party Litigation:
Class Action
Judge:
Firms
- Brodsky Smith
- Faruqi & Faruqi
- Gibson Dunn
- Glancy Prongay
- Labaton Keller
- Milberg Coleman
- Pomerantz LLP
- Rosen Law Firm PA
- Westerman Law Corp.
- Wolf Haldenstein
Companies
Sectors & Industries:
-
March 29, 2016
Arrowhead Ducks Investor Suit Over Hep B Drug Trial
After tentatively green-lighting investors' claims earlier this year that Arrowhead Research Corp. overstated Hepatitis B vaccine trial results, a California federal judge tossed the proposed class action on Tuesday, saying the suit was too thin on specifics.
-
January 05, 2016
Arrowhead Can't Ditch Investor Suit Over Hep B Drug Trial
A California judge on Tuesday tentatively refused to dismiss a putative shareholder class action against Arrowhead Research Corp. over claims that the biopharmaceuticals maker misled investors about the progress of human trials for its hepatitis B vaccine, inflating its stock.